Nirma acquires majority stake in Glenmark Life Sciences
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Launch of Indian public health standards for Ayush healthcare facilities
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated